Bionor Immuno AS Company Profile

12:43 EDT 24th June 2018 | BioPortfolio

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases for which there is currently no effective vaccine or where existing treatments are poorly effective. Bionor Immuno AS aims to develop its therapeutic products through phase II clinical trials. Phase III clinical trials, manufacturing and marketing of finished products will be done in co-operation with a licensing partner


P.O. Box 1823


Phone: 47 35 50 57 50
Fax: 47 35 50 57 01

News Articles [285 Associated News Articles listed on BioPortfolio]

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

Immuno-PCR: A Highly Sensitive Method of Immunodetection

Researchers have relied on immunodetection techniques such as Western blotting, flow cytometry and Enzyme-Linked Immunosorbent Assay (ELISA) for years, but immuno-PCR is a relatively new method. By me...

Phase II most common among immuno-oncology trials, 2008-2017

GlobalData has reviewed the phase of global clinical trials in the immuno-oncology (IO) space that were initiated between 2008 and...Read More... The post Phase II most common among immuno-oncology tr...

The Next Immuno-oncology Frontier?

Here’s some strong evidence for what could be the next wave of immuno-oncology: combining a TLR9 ligand with an OX40 antibody. We’re all going to have to get familiar with that sort of tal...

AbbVie Picks Up Dong-A Candidate As It Makes Immuno-Onc Inroads

Dong-A ST has scored a major early success in its inroads into cancer R&D through a sizable immuno-oncology deal with...  

Merck Boosts Immuno-oncology with Viralytics Buy

US drugmakerMerck & Co. has agreed to buy Australia’s Viralytics for $394 million, in a deal that will boost its immuno-oncology portfolio.

Syngene teams with immuno-oncology firm to provide ‘greater value-added services’

Syngene International has inked a non-exclusive partnering agreement with the emerging immuno-oncology company Zumutor Biologics after collaborating for more than a year.

BMS Announces Expansion of the International Immuno-Oncology Network with Addition of Yale Cancer Center

NewsBristol-Myers Squibb Company announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration between Bristol-Myers Squibb and ac...

Drugs and Medications [0 Results]


PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE).

Minimal Information about an Immuno-Peptidomics Experiment (MIAIPE) is an initiative of the members of the Human Immuno-Peptidome Project (HIPP), an international program organized by the Human Proteo...

Rational design and identification of immuno-oncology drug combinations.

Clinical trials investigating immuno-oncology (IO) drug combinations are largely based on empiricism or limited non-clinical evaluations. This study identified the current combination IO drug clinical...

Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.

Cryptococcal antigen (CrAg) screening at point of care could improve cryptococcal meningitis prevention where laboratory resources are limited. We evaluated the accuracy of Immuno-Mycologics (IMMY, No...

Association of Melatonin Production with Seasonal Changes, Low Temperature, and Immuno-Responses in Hamsters.

Seasonal changes impact the melatonin production and immuno-activities in vertebrates. This is believed due to the photoperiodic alterations of the different seasons which impact the functions of pine...

Expression and Targeting of Tumor Markers in GelfoamHistoculture: Potential Individualized Assays for Immuno-Oncology.

Tumor-specific antigens are important in the study of tumor biology, tumor diagnosis, and prognosis and as targets for tumor therapy. This chapter reviews patient colon, breast, and ovarian tumors in ...

Clinical Trials [918 Associated Clinical Trials listed on BioPortfolio]

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

The study evaluates the safety and effect of intralymphatic allergen specific immunotherapy in increasing doses. Patients that have already undergone subcutaneous immunotherapy will be tre...

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

The purpose of this study is to determine the safety of making and giving Epstein-Barr virus (EBV) immunotherapy products to subjects with nasopharyngeal carcinoma (NPC) associated with EB...

Immunotherapy in Autoimmune Encephalitis

The study is to explore the treatment effects and long-term prognosis (12 months and 24 months after immunotherapy) by comparing the plasma exchange (PE) combined with medication therapy w...

Companies [85 Associated Companies listed on BioPortfolio]

Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases ...

Bionor AS

Bionor is a biotechnology company founded in 1985 developing products for human and veterinarian medicine including aqua culture. For the last 10 years Bionor has increased its HIV related activities ...

Immuno Laboratories

Headquartered in Fort Lauderdale, Florida, Immuno Laboratories is widely recognized as one of the leading food and environmental allergy testing facilities in the world. Since 197...

Immunotech Laboratories, Inc.

Headquartered in Monrovia, CA, Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitati...


SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, reta...

More Information about "Bionor Immuno AS" on BioPortfolio

We have published hundreds of Bionor Immuno AS news stories on BioPortfolio along with dozens of Bionor Immuno AS Clinical Trials and PubMed Articles about Bionor Immuno AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bionor Immuno AS Companies in our database. You can also find out about relevant Bionor Immuno AS Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record